Full Archive

The Ultimate Toy

In case anyone hasn’t noticed there is a virtual toy fair going on this week with ATTD. Yes lots of data, lots of way cool whiz bang lots of pontificating and in the end nothing much really changes all that much. That is unless you’re the CEO of the most innovative toy in diabetes history which is why we are so pleased to release another Wacky World of Diabetes podcast...

Does it matter?

One day someone will have to explain to us how a company that once dominated a market only to screw it up because of their own arrogance should be given the benefit of the doubt. This is basically what Medtronic is asking investors to do when it comes to their still struggling diabetes unit. They want to be given yet another chance as this is not the first not even...

a

News, notes and other things

While the FDA continues to deal with the backlog created by Covid things in Europe seem to be moving a bit quicker. Today Medtronic announced they have obtained CE marks for their Guardian 4 sensor plus expanded functionality for their InPen system. Per a company issued press release; “Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2...

On a roll

The Padres and White Sox aren’t the only teams on a roll recently as here at Diabetic Investor we continue to knock out podcasts. Now before we get into todays edition of the Wacky World a few items 1. The Wacky World of Diabetes Podcast is FREE and can be shared with anyone 2. Podcasts can be found on our site, Apple and Spotify – please note podcasts are found searching The...

Next Steps and they are NOT obvious

Every once in a while a drug comes along that seems to have blockbuster written all over it. In the case of tirzepatide from Lilly we’d even go as far as mega-blockbuster. To say that tirzepatide is widely anticipated is like saying people are looking forward to summer. Now that the drug has completed its extensive clinical program and is set to be submitted to the FDA a complex set of...

Yet another GREAT podcast

We could not be more pleased to deliver yet another outstanding edition of The Wacky World of Diabetes podcast. Our guest today is a truly outstanding individual who has made and continues to make a deep and lasting impression on our wacky world. Please welcome to my Wacky World Phil Southerland CEO &Founder of Team Novo Nordisk, CEO & Founder of SuperSapiens, author and all-around great guy. ...

Just what is it?

The diabetes device sector in some respects isn’t all that complex. As one former executive said there are three things you need to be successful. Can you build it, can you sell and support it and most importantly of all can you get it paid for. Traditionally making money is also pretty simple as once approved and on formulary device makers aren’t paid by the patient but the patients’ health...